A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21
Condition: Malaria, Plasmodium Falciparum Intervention: Biological: Matrix-M with RH5.2 VLP and/or R21 Sponsors: University of Oxford; European and Developing Countries Clinical Trials Partnership (EDCTP); Medical Research Council Unit The Gambia at the LSHTM (MRCG) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Clinical Trials | Gambia Health | Malaria | Malaria Vaccine | Partnerships | Research | Study | Vaccines